Mirati Ther Analysis
| MRTXDelisted Stock | USD 31.32 0.15 0.48% |
Mirati Ther is fairly valued with Real Value of 30.48 and Hype Value of 31.32. The main objective of Mirati Ther delisted stock analysis is to determine its intrinsic value, which is an estimate of what Mirati Ther is worth, separate from its market price. There are two main types of Mirati Ther's stock analysis: fundamental analysis and technical analysis.
The Mirati Ther stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Mirati Ther is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Mirati Stock trading window is adjusted to America/New York timezone.
Mirati |
Mirati Stock Analysis Notes
About 98.0% of the company shares are owned by institutional investors. The book value of Mirati Ther was now reported as 13.5. The company recorded a loss per share of 12.18. Mirati Ther had not issued any dividends in recent years. The entity had 1:50 split on the 3rd of July 2013. Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California. Mirati Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people. To find out more about Mirati Ther contact David Meek at 858 332 3410 or learn more at https://www.mirati.com.Mirati Ther Investment Alerts
| Mirati Ther is not yet fully synchronised with the market data | |
| Mirati Ther has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.44 M. Net Loss for the year was (740.87 M) with loss before overhead, payroll, taxes, and interest of (519.79 M). | |
| Mirati Ther currently holds about 1.19 B in cash with (570.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.41. | |
| Over 98.0% of the company shares are owned by institutional investors |
Mirati Ther Upcoming and Recent Events
Earnings reports are used by Mirati Ther to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Mirati Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.12 B.Mirati Ther Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mirati Ther insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mirati Ther's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mirati Ther insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ondrey Aaron over six months ago Acquisition by Ondrey Aaron of 17021 shares of Mirati Ther subject to Rule 16b-3 | ||
Ondrey Aaron over a year ago Mirati Ther exotic insider transaction detected | ||
Moriarty John B over a year ago Mirati Ther exotic insider transaction detected | ||
Laurie Stelzer over a year ago Sale by Laurie Stelzer of 4647 shares of Mirati Ther | ||
David Meek over a year ago Sale by David Meek of 3179 shares of Mirati Ther |
Mirati Ther Outstanding Bonds
Mirati Ther issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mirati Ther uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mirati bonds can be classified according to their maturity, which is the date when Mirati Ther has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Mirati Ther Predictive Daily Indicators
Mirati Ther intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mirati Ther stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Mirati Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Mirati Ther prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mirati shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Mirati Ther. By using and applying Mirati Stock analysis, traders can create a robust methodology for identifying Mirati entry and exit points for their positions.
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California. Mirati Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Mirati Ther to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |